We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

271 hedge funds and large institutions have $2.18B invested in Adaptive Biotechnologies in 2025 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 93 increasing their positions, 81 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 25

54% more call options, than puts

Call options by funds: $821K | Put options by funds: $534K

26% more capital invested

Capital invested by funds: $1.73B → $2.18B (+$449M)

15% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 81

12% more funds holding

Funds holding: 242 → 271 (+29)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.02% less ownership

Funds ownership: 97.52% → 95.5% (-2%)

Holders
271
Holders Change
+29
Holders Change %
+11.98%
% of All Funds
3.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
55
Increased
93
Reduced
81
Closed
25
Calls
$821K
Puts
$534K
Net Calls
+$287K
Net Calls Change
-$1.78M

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$33.3M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$25.1M
3
Deutsche Bank
Deutsche Bank
Germany
+$18.8M
4
Macquarie Group
Macquarie Group
Australia
+$17.6M
5
Jennison Associates
Jennison Associates
New York
+$14.8M

Top Sellers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
-$72.9M
2
B
Braidwell
Connecticut
-$38.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$12.8M
4
AIM
ARK Investment Management
Florida
-$10.4M
5
JP Morgan Chase
JP Morgan Chase
New York
-$9.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
51
Wellington Management Group
Massachusetts
$7.5M +$6.11M +501,084 New
RPAM
52
Rhenman & Partners Asset Management
Sweden
$7.41M +$6.03M +495,000 New
Cerity Partners
53
Cerity Partners
New York
$6.47M -$270K -22,198 -5%
Bank of New York Mellon
54
Bank of New York Mellon
New York
$6.35M +$170K +13,957 +3%
Millennium Management
55
Millennium Management
New York
$5.94M -$7.52M -617,332 -61%
Russell Investments Group
56
Russell Investments Group
United Kingdom
$5.76M -$2.5M -204,901 -35%
EI
57
EAM Investors
California
$5.28M +$452K +37,081 +12%
HIS
58
Harvest Investment Services
Illinois
$5.15M +$2.15M +176,235 +105%
ZP
59
Zimmer Partners
New York
$4.95M +$950K +77,934 +31%
Fidelity Investments
60
Fidelity Investments
Massachusetts
$4.85M +$407K +33,388 +11%
Allianz Asset Management
61
Allianz Asset Management
Germany
$4.81M +$2.95M +242,474 +306%
Point72 Asset Management
62
Point72 Asset Management
Connecticut
$4.78M -$12.8M -1,054,452 -77%
CCM
63
Cinctive Capital Management
New York
$4.64M -$3.72M -305,431 -50%
Prudential Financial
64
Prudential Financial
New Jersey
$4.64M -$1.26M -103,730 -25%
AWM
65
Affinity Wealth Management
Delaware
$4.54M +$3.7M +303,533 New
LCG
66
Lisanti Capital Growth
New York
$4.48M +$3.65M +299,180 New
CM
67
Castleark Management
Illinois
$4.46M +$3.63M +298,074 New
Polen Capital Management
68
Polen Capital Management
Florida
$4.36M +$1.81M +148,940 +105%
CSS
69
Cubist Systematic Strategies
Connecticut
$4.34M -$2.06M -168,783 -37%
Barclays
70
Barclays
United Kingdom
$4.3M -$918K -75,360 -21%
Raymond James Financial
71
Raymond James Financial
Florida
$4.21M +$163K +13,398 +5%
Renaissance Technologies
72
Renaissance Technologies
New York
$4.18M +$2.8M +229,800 +461%
JAM
73
Jupiter Asset Management
United Kingdom
$4.06M +$2.69M +221,158 +443%
UBS Group
74
UBS Group
Switzerland
$3.8M -$2.45M -201,426 -44%
Legal & General Group
75
Legal & General Group
United Kingdom
$3.68M -$38.9K -3,193 -1%
1 2
3
4 5

ADPT Hedge Fund Activity: Q3 2025 in Review

271 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q3 2025, worth a combined $2.18B — up 26% from $1.73B a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new ADPT positions and 25 closed out — a net gain of 30 holders — while 93 added to existing stakes and 81 trimmed.

The largest buyer was Ameriprise, adding an estimated $33.3M. The largest seller was Rubric Capital Management (New York), exiting entirely with an estimated $72.9M sold.

  • 271 institutional investors held Adaptive Biotechnologies (ADPT) as of Q3 2025, up from 242 in Q2 2025.
  • Funds reported $2.18B of Adaptive Biotechnologies stock for Q3 2025, up 26% quarter-over-quarter.
  • 55 funds opened new Adaptive Biotechnologies positions in Q3 2025 and 25 closed out, a net change of +30 holders.
  • The largest Adaptive Biotechnologies buyer in Q3 2025 was Ameriprise, an estimated $33.3M added.
  • The largest Adaptive Biotechnologies seller in Q3 2025 was Rubric Capital Management (New York), an estimated $72.9M sold.

Based on aggregated 13F filings for Q3 2025.